Paul, Thomas

[["dc.bibliographiccitation.journal","Journal of Interventional Cardiac Electrophysiology"],["dc.contributor.author","Krause, Ulrich"],["dc.contributor.author","Müller, Matthias J."],["dc.contributor.author","Schneider, Heike E."],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2022-05-02T08:09:42Z"],["dc.date.available","2022-05-02T08:09:42Z"],["dc.date.issued","2022"],["dc.description.abstract","Abstract Background Prevalence of atrial fibrillation (AF) is increasing in adult patients with congenital heart disease (CHD). Experience using the cryoballoon to achieve pulmonary vein isolation (PVI) in adult CHD patients is limited. The aim of the present study was to assess the value of PVI by cryoballoon in adult CHD patients and to evaluate the significance of additional radiofrequency (RF) ablation of atrial tachycardia (AT). Patients and methods Prospective data analysis; all patients with CHD and AF and PVI using the cryoballoon from January 2017 through November 2021 were included. Results Nineteen patients with various types of CHD were included. Median age was 58 (IQR 47–63) years. A total of 12/19 (63%) patients had had RF ablation of right atrial AT before. Median procedure duration was 225 (IQR 196–261) min. Median fluoroscopy time was 12.3 (IQR 5.2–19.5) min and median freeze time was 32 (IQR 28–36.3) min. Procedural success was achieved in all patients. Additional RF catheter ablation of intraatrial reentrant tachycardia within the left atrium was performed in 3/19 (16%) subjects and within the right atrium in 6/19 (32%) patients. Median follow-up was 26 (IQR 9–49) months. Excluding a 90-day blanking period, recurrence of AF was observed in 6/19 subjects (32%). After one redo procedure deploying RF energy only, 84% of all patients remained free from recurrence. Phrenic nerve palsy was observed in 1 subject. Conclusion Results after PVI using the cryoballoon plus additional RF ablation of AT were promising (84% success including one redo procedure). Success of AF ablation was unsatisfactory in all patients who had no additional AT ablation. Ablation of any AT in these patients should therefore be considered in addition to PVI."],["dc.description.abstract","Abstract Background Prevalence of atrial fibrillation (AF) is increasing in adult patients with congenital heart disease (CHD). Experience using the cryoballoon to achieve pulmonary vein isolation (PVI) in adult CHD patients is limited. The aim of the present study was to assess the value of PVI by cryoballoon in adult CHD patients and to evaluate the significance of additional radiofrequency (RF) ablation of atrial tachycardia (AT). Patients and methods Prospective data analysis; all patients with CHD and AF and PVI using the cryoballoon from January 2017 through November 2021 were included. Results Nineteen patients with various types of CHD were included. Median age was 58 (IQR 47–63) years. A total of 12/19 (63%) patients had had RF ablation of right atrial AT before. Median procedure duration was 225 (IQR 196–261) min. Median fluoroscopy time was 12.3 (IQR 5.2–19.5) min and median freeze time was 32 (IQR 28–36.3) min. Procedural success was achieved in all patients. Additional RF catheter ablation of intraatrial reentrant tachycardia within the left atrium was performed in 3/19 (16%) subjects and within the right atrium in 6/19 (32%) patients. Median follow-up was 26 (IQR 9–49) months. Excluding a 90-day blanking period, recurrence of AF was observed in 6/19 subjects (32%). After one redo procedure deploying RF energy only, 84% of all patients remained free from recurrence. Phrenic nerve palsy was observed in 1 subject. Conclusion Results after PVI using the cryoballoon plus additional RF ablation of AT were promising (84% success including one redo procedure). Success of AF ablation was unsatisfactory in all patients who had no additional AT ablation. Ablation of any AT in these patients should therefore be considered in addition to PVI."],["dc.description.sponsorship","Georg-August-Universität Göttingen"],["dc.identifier.doi","10.1007/s10840-022-01213-0"],["dc.identifier.pii","1213"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/107443"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-561"],["dc.relation.eissn","1572-8595"],["dc.relation.issn","1383-875X"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Catheter ablation of atrial fibrillation using 2nd-generation cryoballoon in congenital heart disease patients — significance of RF ablation of additional atrial macro-reentrant tachycardia"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","e0246169"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","PLoS One"],["dc.bibliographiccitation.volume","16"],["dc.contributor.author","Geyer, Siegfried"],["dc.contributor.author","Fleig, Katharina"],["dc.contributor.author","Norozi, Kambiz"],["dc.contributor.author","Röbbel, Lena"],["dc.contributor.author","Paul, Thomas"],["dc.contributor.author","Müller, Matthias"],["dc.contributor.author","Dellas, Claudia"],["dc.contributor.editor","Leist, Anja K."],["dc.date.accessioned","2021-04-14T08:28:04Z"],["dc.date.available","2021-04-14T08:28:04Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1371/journal.pone.0246169"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82494"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.relation.eissn","1932-6203"],["dc.title","Life chances after surgery of congenital heart disease: A case-control-study of inter- and intragenerational social mobility over 15 years"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","S15"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Journal of Electrocardiology"],["dc.bibliographiccitation.lastpage","S16"],["dc.bibliographiccitation.volume","40"],["dc.contributor.author","Hessling, Gabriele"],["dc.contributor.author","Rosenthal, Eric"],["dc.contributor.author","Paul, Thomas"],["dc.contributor.author","Schnelder, Heike"],["dc.date.accessioned","2018-11-07T11:06:51Z"],["dc.date.available","2018-11-07T11:06:51Z"],["dc.date.issued","2007"],["dc.identifier.doi","10.1016/j.jelectrocard.2006.10.020"],["dc.identifier.isi","000243511700007"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/52414"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Churchill Livingstone Inc Medical Publishers"],["dc.publisher.place","Philadelphia"],["dc.relation.conference","33rd Annual Congress of the International-Society-of-Electrocardiology/47th International Symposium on Vectorcardiography"],["dc.relation.eventlocation","Cologne, GERMANY"],["dc.relation.issn","0022-0736"],["dc.title","Management of arrhythmias in children"],["dc.type","conference_paper"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Journal of the American College of Cardiology"],["dc.bibliographiccitation.volume","45"],["dc.contributor.author","Kriebel, T. A."],["dc.contributor.author","Broistedt, C."],["dc.contributor.author","Kroll, Maja"],["dc.contributor.author","Jux, Christian"],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2018-11-07T08:28:54Z"],["dc.date.available","2018-11-07T08:28:54Z"],["dc.date.issued","2005"],["dc.format.extent","115A"],["dc.identifier.isi","000226808200502"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/16525"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Elsevier Science Inc"],["dc.publisher.place","New york"],["dc.relation.conference","54th Annual Scientific Session of the American-College-of-Cardiology"],["dc.relation.eventlocation","Orlando, FL"],["dc.relation.issn","0735-1097"],["dc.title","Cryoablation of supraventricular tachycardia in children and adolescents: Predictive value of cryomapping"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","106"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Europace"],["dc.bibliographiccitation.lastpage","113"],["dc.bibliographiccitation.volume","21"],["dc.contributor.author","Krause, Ulrich"],["dc.contributor.author","Müller, Matthias J"],["dc.contributor.author","Wilberg, Yannic"],["dc.contributor.author","Pietzka, Matthias"],["dc.contributor.author","Backhoff, David"],["dc.contributor.author","Ruschewski, Wolfgang"],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2020-12-10T18:19:09Z"],["dc.date.available","2020-12-10T18:19:09Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1093/europace/euy219"],["dc.identifier.eissn","1532-2092"],["dc.identifier.issn","1099-5129"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/75140"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","33"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Clinical Research in Cardiology"],["dc.bibliographiccitation.lastpage","42"],["dc.bibliographiccitation.volume","102"],["dc.contributor.author","Schneider, Heike E."],["dc.contributor.author","Steinmetz, Michael"],["dc.contributor.author","Krause, Ulrich J."],["dc.contributor.author","Kriebel, Thomas"],["dc.contributor.author","Ruschewski, Wolfgang"],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2018-11-07T09:30:45Z"],["dc.date.available","2018-11-07T09:30:45Z"],["dc.date.issued","2013"],["dc.description.abstract","Left cardiac sympathetic denervation (LCSD) may be a therapeutic adjunct for young patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) and long QT syndrome (LQTS) who are not fully protected by beta-blockade. The objective of this analysis was to report our institutional experience with LSCD in young patients for the management of life-threatening ventricular arrhythmias in CPVT and LQTS. Ten young patients with CPVT and LQTS underwent transaxillary LSCD at our institution. Mean age at surgery was 14.0 (range 3.9-42) years, mean body weight was 45.7 (range 15.5-90) kg. Five patients had the clinical diagnosis of CPVT, three were genotype positive for a mutation in the ryanodine-receptor-2-gene. Four of five LQTS patients were genotype positive. Indications for LCSD were recurrent syncope, symptomatic episodes of ventricular tachycardias and/or internal cardioverter-defibrillator (ICD) discharges, and aborted cardiac arrest despite high doses of beta-blockers. LCSD was performed via the transaxillary approach. No significant complications were observed. Two patients already had an ICD, 6 patients received an ICD at the same operation or shortly thereafter. Median length of follow-up after LCSD was 2.3 (range 0.6-3.9) years. After LCSD a marked reduction in arrhythmia burden and cardiac events was observed in all patients while medication was continued. None of the patients had any further ICD discharge for sustained VT. After LCSD, arrhythmia burden could significantly be reduced in all our young patients with CPVT and LQTS."],["dc.identifier.doi","10.1007/s00392-012-0492-7"],["dc.identifier.isi","000313070900004"],["dc.identifier.pmid","22821214"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/8805"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/31382"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","Heidelberg"],["dc.relation.issn","1861-0684"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","European Journal of Pediatrics"],["dc.bibliographiccitation.volume","168"],["dc.contributor.author","Kriebel, TA"],["dc.contributor.author","Schneider, H."],["dc.contributor.author","Kroll, Maja"],["dc.contributor.author","Selle, Jakob"],["dc.contributor.author","Quentin, Thomas"],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2018-11-07T08:31:59Z"],["dc.date.available","2018-11-07T08:31:59Z"],["dc.date.issued","2009"],["dc.format.extent","379"],["dc.identifier.isi","000262826600039"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/17242"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.publisher.place","New york"],["dc.relation.issn","0340-6199"],["dc.title","Histological characterisation of cryolesions and results of intracoronary ultrasound and coronary angiography after energy application at growing myocardium"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.journal","Cardiology in the Young"],["dc.bibliographiccitation.lastpage","5"],["dc.contributor.author","Gonzalez Corcia, M Cecilia"],["dc.contributor.author","Cohen, Mitchell I"],["dc.contributor.author","Paul, Thomas"],["dc.contributor.author","Skinner, Jonathan R"],["dc.contributor.author","Shah, Maully"],["dc.date.accessioned","2022-05-02T07:47:05Z"],["dc.date.available","2022-05-02T07:47:05Z"],["dc.date.issued","2022"],["dc.description.abstract","Abstract Background: The Pediatric and Congenital Electrophysiology Society (PACES) is a global organisation committed to the care of children and adults with CHD and arrhythmias. Objective: To evaluate the global needs and potential inequities as it relates to cardiac implantable electronic devices. Methods: ARROW (Assessment of Rhythm Resources arOund the World) is an online survey about cardiac implantable electronic devices, sent electronically to physicians within the field of Cardiology, Pediatric Cardiology, Electrophysiology and Pediatric Electrophysiology. Results: ARROW received 42 responders from 28 countries, 50% from low-/middle-income regions. The main differences between low-/middle- and high-income regions include availability of expertise on paediatric electrophysiology (50% versus 93%, p < 00.5) and possibility to perform invasive procedures (35% versus 93%, p < 0.005). Implant of devices in low-income areas relies significantly on patient’s resources (71%). The follow-up of the devices is on the hands of paediatric cardiologist/electrophysiologist in higher resources centres (93% versus 50%, p < 0.05). Conclusions: The ARROW survey represents an initial assessment of the geographical characteristics in the field of Pediatric Electrophysiology. The next step is to make this “state of the art” more extensive to other aspects of the expertise. The relevance of collecting this data before the World Congress of Pediatric Cardiology and Cardiac Surgery (WCPCCS) in 2023 in Washington DC was emphasised in order to share the resulting information with the international community and set a plan of action to assist the development of arrhythmia services for children within developing regions of the world."],["dc.description.abstract","Abstract Background: The Pediatric and Congenital Electrophysiology Society (PACES) is a global organisation committed to the care of children and adults with CHD and arrhythmias. Objective: To evaluate the global needs and potential inequities as it relates to cardiac implantable electronic devices. Methods: ARROW (Assessment of Rhythm Resources arOund the World) is an online survey about cardiac implantable electronic devices, sent electronically to physicians within the field of Cardiology, Pediatric Cardiology, Electrophysiology and Pediatric Electrophysiology. Results: ARROW received 42 responders from 28 countries, 50% from low-/middle-income regions. The main differences between low-/middle- and high-income regions include availability of expertise on paediatric electrophysiology (50% versus 93%, p < 00.5) and possibility to perform invasive procedures (35% versus 93%, p < 0.005). Implant of devices in low-income areas relies significantly on patient’s resources (71%). The follow-up of the devices is on the hands of paediatric cardiologist/electrophysiologist in higher resources centres (93% versus 50%, p < 0.05). Conclusions: The ARROW survey represents an initial assessment of the geographical characteristics in the field of Pediatric Electrophysiology. The next step is to make this “state of the art” more extensive to other aspects of the expertise. The relevance of collecting this data before the World Congress of Pediatric Cardiology and Cardiac Surgery (WCPCCS) in 2023 in Washington DC was emphasised in order to share the resulting information with the international community and set a plan of action to assist the development of arrhythmia services for children within developing regions of the world."],["dc.identifier.doi","10.1017/S1047951122000014"],["dc.identifier.pii","S1047951122000014"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/107209"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-561"],["dc.relation.eissn","1467-1107"],["dc.relation.issn","1047-9511"],["dc.rights.uri","https://www.cambridge.org/core/terms"],["dc.title","Preliminary assessment of paediatric electrophysiology cardiac implantable electronic device resources around the world"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","179"],["dc.bibliographiccitation.issue","3"],["dc.bibliographiccitation.journal","Klinische Pädiatrie"],["dc.bibliographiccitation.lastpage","182"],["dc.bibliographiccitation.volume","224"],["dc.contributor.author","Krause, Ulrich J."],["dc.contributor.author","Schneider, Heike E."],["dc.contributor.author","Webel, Martin"],["dc.contributor.author","Paul, Thomas"],["dc.date.accessioned","2018-11-07T09:10:35Z"],["dc.date.available","2018-11-07T09:10:35Z"],["dc.date.issued","2012"],["dc.description.abstract","Background: Aortic thrombosis is rarely observed in neonates and infants. Underlying conditions include the presence of umbilical artery catheters, thrombosed aneurysm of the ductus arteriosus, sepsis and different states of inherited thrombophilia. Treatment options include anticoagulation, thrombolytic therapy and thrombectomy. Due to the lack of large studies, neither diagnosis nor treatment of neonatal aortic thrombosis are standardized. Patients: From 2008-2010, 1 neonate and 1 infant were admitted to our hospital with symptomatic aortic thrombosis. Methods and Results: In both patients, diagnosis was made by Doppler ultrasound. Both patients were effectively treated with recombinant tissuetype plasminogen activator. Diagnosis and treatment of 2 infants with symptomatic aortic thrombosis are discussed and the literature is reviewed. Conclusions: Since aortic thrombosis is a life-threatening condition, early diagnosis by Doppler ultrasound is mandatory to initiate treatment without delay. Thrombolytic therapy is a safe measure to treat this condition if administered with caution and if the patient has not suffered from serious complications such as mesenteric infarction or renal failure prior to begin of therapy."],["dc.identifier.doi","10.1055/s-0031-1295421"],["dc.identifier.isi","000305171500013"],["dc.identifier.pmid","22377739"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/26525"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.issn","0300-8630"],["dc.title","Thrombosis of the Aorta Abdominalis in Infants - Diagnosis and Thrombolytic Therapy"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","2185"],["dc.bibliographiccitation.issue","25"],["dc.bibliographiccitation.journal","Circulation"],["dc.bibliographiccitation.lastpage","2193"],["dc.bibliographiccitation.volume","131"],["dc.contributor.author","De Ferrari, Gaetano M."],["dc.contributor.author","Dusi, Veronica"],["dc.contributor.author","Spazzolini, Carla"],["dc.contributor.author","Bos, J. Martijn"],["dc.contributor.author","Abrams, Dominic J."],["dc.contributor.author","Berul, Charles I."],["dc.contributor.author","Crotti, Lia"],["dc.contributor.author","Davis, Andrew M."],["dc.contributor.author","Eldar, Michael"],["dc.contributor.author","Kharlap, Maria"],["dc.contributor.author","Khoury, Asaad"],["dc.contributor.author","Krahn, Andrew D."],["dc.contributor.author","Leenhardt, Antoine"],["dc.contributor.author","Moir, Christopher R."],["dc.contributor.author","Odero, Attilio"],["dc.contributor.author","Olde Nordkamp, Louise"],["dc.contributor.author","Paul, Thomas"],["dc.contributor.author","Roses i Noguer, Ferran"],["dc.contributor.author","Shkolnikova, Maria"],["dc.contributor.author","Till, Jan"],["dc.contributor.author","Wilde, Arthur A. M."],["dc.contributor.author","Ackerman, Michael J."],["dc.contributor.author","Schwartz, Peter J."],["dc.date.accessioned","2018-11-07T09:55:42Z"],["dc.date.available","2018-11-07T09:55:42Z"],["dc.date.issued","2015"],["dc.description.abstract","Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic disorder causing life-threatening arrhythmias whenever sympathetic activity increases. -Blockers are the mainstay of therapy; when they fail, implantable cardioverter-defibrillators (ICDs) are used but often cause multiple shocks. Preliminary results with flecainide appear encouraging. We proposed left cardiac sympathetic denervation (LCSD) as useful additional therapy, but evidence remains anecdotal. Methods and Results We report 63 patients with CPVT who underwent LCSD as secondary (n=54) or primary (n=9) prevention. The median post-LCSD follow-up was 37 months. The 9 asymptomatic patients remained free of major cardiac events. Of the 54 patients with prior major cardiac events either on (n=38) or off (n=16) optimal medical therapy, 13 (24%) had at least 1 recurrence: 0 patients had an aborted cardiac arrest, 2 patients had syncope only, 10 patients had 1 appropriate ICD discharges, and 1 patient died suddenly. The 1- and 2-year cumulative event-free survival rates were 87% and 81%. The percentage of patients with major cardiac events despite optimal medical therapy (n=38) was reduced from 100% to 32% (P<0.001) after LCSD, and among 29 patients with a presurgical ICD, the rate of shocks dropped by 93% from 3.6 to 0.6 shocks per person per year (P<0.001). Patients with an incomplete LCSD (n=7) were more likely to experience major cardiac events after LCSD (71% versus 17%; P<0.01) than those with a complete LCSD. Conclusions LCSD is an effective antifibrillatory intervention for patients with CPVT. Whenever syncope occurs despite optimal medical therapy, LCSD could be considered the next step rather than an ICD and could complement ICDs in patients with recurrent shocks."],["dc.identifier.doi","10.1161/CIRCULATIONAHA.115.015731"],["dc.identifier.isi","000360528400005"],["dc.identifier.pmid","26019152"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/36810"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Lippincott Williams & Wilkins"],["dc.relation.issn","1524-4539"],["dc.relation.issn","0009-7322"],["dc.title","Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia The Role of Left Cardiac Sympathetic Denervation"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]